[1] |
马芬,孙延生,王莉平. 联合检测血清 Hcy、Cys C及β-HCG在预测与判断妊高征程度的临床意义[J]. 中国实验诊断学,2013,17(4):739-740.
|
[2] |
徐生梅,颜群. 血清中血管紧张素转换酶活性测定及临床应用[J]. 临床检验杂志,2007,25(6):462.
|
[3] |
陈柏坤,卓佳,周垒碧. 妊娠高血压综合征患者血管紧张素转换酶基因多态性研究[J]. 检验医学,2006,21(1):39-41.
|
[4] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志,2015,50(10):721-728.
|
[5] |
陈飞. HCY,D-D,hc-CRP联合检测在妊娠期高血压疾病诊断中的临床意义[J]. 诊断学理论与实践,2013,12(6):628-630.
|
[6] |
COOPER A C,ROBINSON G,VINSON G P,et al.The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy[J]. Placenta,1999,20(5-6):467-474.
|
[7] |
喻玲,马玉平,丁依玲. 血管紧张素转换酶在子痫前期胎盘组织中的表达及活性变化[J]. 中南大学学报(医学版),2007,32(3):498-502.
|
[8] |
SERNRI G G,BODDI M,CECIONI I,et al.Cardiac angiotensin Ⅱ formation in the clinical course of heart failure and its relationship with left ventricular function[J]. Circ Res,2001,88(9):961-968.
|
[9] |
ITO M,ITAKURA A,OHNO Y,et al.Possible activation of the renin-angiotensin system in the feto-placental unit in preeclampsia[J]. J Clin Endocrinol Metab,2002,87(4):1871-1878.
|
[10] |
BRAMELD J M,HOLD R,PIPKIN F B.Regional variation in angiotensin converting enzyme activity in the human placenta[J]. Placenta,2011,32(11):906-908.
|
[11] |
ZAWIEJSKA A,WENDER-OZEGOWSKA E,ICIEK R,et al.Concentrations of endothelial nitric oxide synthase,angiotensin-converting enzyme,vascular endothelial growth factor and placental growth factor in maternal blood and maternal metabolic status in pregnancy complicated by hypertensive disorders[J]. J Hum Hypertens,2014,28(11):670-676.
|
[12] |
MITSUI T,MASUYAMA H,MAKI J,et al.Differences in uterine artery blood flow and fetal growth between the early and late onset of pregnancy-induced hypertension[J]. J Med Ultrason(2001),2016,43(4):509-517.
|
[13] |
陈国新,陶珊花,冼小珍,等. 血清胱抑素C、尿β2微球蛋白和尿微量白蛋白水平对妊娠高血压早期肾损伤的临床意义[J]. 中国现代医生,2015,53(5):92-94.
|
[14] |
潘秀林,朱玩秀. 妊高症患者血清 CysC,HCY及mALB联合检测的临床意义[J]. 现代检验医学杂志,2015,30(3):145-146.
|
[15] |
李海燕. 血清视黄醇结合蛋白、胱抑素C以及β2微球蛋白联合检测在妊高症肾损伤中的价值[J]. 中国实用医药,2016,11(30):141-142.
|